The p47phox mouse knock-out model of chronic granulomatous disease

Chronic granulomatous disease (CGD) is caused by a congenital defect in phagocyte reduced nicotinamide dinucleotide phosphate (NADPH) oxidase production of superoxide and related species. It is characterized by recurrent life-threatening bacterial and fungal infections and tissue granuloma formation. We have created a mouse model of CGD by targeted disruption of p47phox, one of the genes in which mutations cause human CGD. Identical to the case in human CGD, leukocytes from p47phox-/- mice produced no superoxide and killed staphylococci ineffectively. p47phox-/- mice developed lethal infections and granulomatous inflammation similar to those encountered in human CGD patients. This model mirrors human CGD and confirms a critical role for the phagocyte NADPH oxidase in mammalian host defense.

[1]  T. Leto,et al.  Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Roos.  The Genetic Basis of Chronic Granulomatous Disease , 1994, Immunological reviews.

[3]  B. Dawson-Saunders,et al.  Basic and Clinical Biostatistics , 1993 .

[4]  Wagner Je,et al.  Epizootic fatal dermatitis in athymic nude mice due to Staphylococcus xylosus. , 1993 .

[5]  R. Lehrer,et al.  Mouse neutrophils lack defensins , 1992, Infection and immunity.

[6]  P. Williamson,et al.  Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  P. Choyke,et al.  The urological manifestations of chronic granulomatous disease. , 1992, The Journal of urology.

[8]  Terry D. Lee,et al.  Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.

[9]  A. Bradley,et al.  Genomic DNA microextraction: a method to screen numerous samples. , 1992, Analytical biochemistry.

[10]  H. Murray,et al.  L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. , 1992, The Journal of infectious diseases.

[11]  A. Abo,et al.  Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1 , 1991, Nature.

[12]  D. Bentley,et al.  Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Orkin,et al.  Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. , 1990, The Journal of clinical investigation.

[14]  J. Curnutte.  Recent advances in chronic granulomatous disease , 1990 .

[15]  H. Malech,et al.  Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. , 1990, Science.

[16]  J. Gallin,et al.  Update on chronic granulomatous diseases of childhood. Immunotherapy and potential for gene therapy. , 1990, JAMA.

[17]  W. Nauseef,et al.  Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system. , 1989, The New England journal of medicine.

[18]  J. Donelson,et al.  Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Malech,et al.  Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. , 1989, Science.

[20]  A. Fischer,et al.  Incidence, severity, and prevention of infections in chronic granulomatous disease. , 1989, The Journal of pediatrics.

[21]  C. Nathan,et al.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.

[22]  R. Johnston,et al.  Clinical features and current management of chronic granulomatous disease. , 1988, Hematology/oncology clinics of North America.

[23]  S. Orkin,et al.  Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Monaco,et al.  Cloning the gene for an inherited human disorder—chronic granulomatous disease—on the basis of its chromosomal location , 1986, Nature.

[25]  R Kemler,et al.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.

[26]  W. Henderson,et al.  Leukotriene production and inactivation by normal, chronic granulomatous disease and myeloperoxidase-deficient neutrophils. , 1983, The Journal of biological chemistry.

[27]  E. Baron,et al.  Elicitation of peritoneal polymorphonuclear neutrophils from mice. , 1982, Journal of immunological methods.

[28]  Z. Cohn,et al.  Antitumor effects of hydrogen peroxide in vivo , 1981, The Journal of experimental medicine.

[29]  P. Ward,et al.  Role of oxygen metabolites in immune complex injury of lung. , 1981, Journal of immunology.

[30]  S. Wolff,et al.  Granulocyte function in the Chediak-Higashi syndrome of mice. , 1974, Blood.

[31]  H. Ochs,et al.  The NBT slide test: a simple screening method for detecting chronic granulomatous disease and female carriers. , 1973, The Journal of pediatrics.

[32]  Malawista Se,et al.  A simple rapid micromethod for detecting chronic granulomatous disease of childhood. , 1970 .

[33]  D. Nathan,et al.  Quantitative nitroblue tetrazolium test in chronic granulomatous disease. , 1968, The New England journal of medicine.

[34]  David A. Williams,et al.  Mouse model of X–linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production , 1995, Nature Genetics.

[35]  T. Fleisher,et al.  Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. , 1995, Journal of immunological methods.

[36]  G. Boivin,et al.  Epizootic fatal dermatitis in athymic nude mice due to Staphylococcus xylosus. , 1993, Laboratory animal science.

[37]  John I. Gallin,et al.  A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. , 1991, The New England journal of medicine.

[38]  L. Greenbaum.  Laboratory Manual of Neutrophil Function , 1987, The Yale Journal of Biology and Medicine.

[39]  E. Robertson.  Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[40]  J. Metcalf,et al.  Laboratory Manual of Neutrophil Function , 1986 .

[41]  S. Malawista,et al.  A simple rapid micromethod for detecting chronic granulomatous disease of childhood. , 1970, The Journal of laboratory and clinical medicine.